News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Regeneus.
RELATED STOCKHEAD STORIES
Health & Biotech
Pharmaxis to get $14m payday after its cystic fibrosis treatment Bronchitol approved by FDA
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Dr Boreham’s Crucible: Regeneus is now riding the stem cell rollercoaster upwards
Experts
Scopo’s powerplays: Investors love an ice queen
News
ASX Small Cap Lunch Wrap: Who’s putting their best foot forward today?
Health & Biotech
Regeneus finally signs that Japan stem cell deal, shares jump 81pc
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Check up: Maybe next week will be better?
Experts
Scopo’s powerplays: Hemp hippies and wellness wonderlands
Experts
Scopo’s health powerplays: Clinical trials are back
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
Health & Biotech
Asia is where health investors are making money this year
Health & Biotech
Check up: Here’s what’s happening with ASX small cap health stocks
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Director Trades
Directors Trades: Even in a big crowd you can still stand out
Health & Biotech
